Literature DB >> 10082225

The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats.

M Yoshimoto1, H Higuchi, M Kamata, K Yoshida, T Shimizu, Y Hishikawa.   

Abstract

In order to investigate the relative efficacy and safety of zopiclone and zolpidem, we compared the effects of higher doses of zopiclone and zolpidem on the frequency of hippocampal theta activity and sleep structure with that of triazolam. Rats were divided into triazolam treatment group (1 mg/kg, 5 mg/kg), zopiclone treatment group (20 mg/kg, 100 mg/kg) and zolpidem treatment group (20 mg/kg, 100 mg/kg). Rats were injected intraperitoneally with these drugs or their vehicle. Polygraphic sleep recording and visual frequency analysis of the hippocampal EEG activity in REM sleep were carried out for 6 h after each injection. Zolpidem, unlike triazolam and zopiclone, had a much milder reducing-effect on the frequency of hippocampal theta activity and suppressing-effect on REM sleep. These results suggest that zolpidem may prove to be a safer hypnotic drug which has fewer or milder side effects than are benzodiazepine and cyclopyrrolone hypnotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082225     DOI: 10.1016/s0924-977x(97)00102-8

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  16 in total

1.  Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice.

Authors:  Chloé Alexandre; Alberto Dordal; Ramon Aixendri; Antonio Guzman; Michel Hamon; Joëlle Adrien
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

Review 2.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

3.  Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation.

Authors:  Viviane S Hambrecht-Wiedbusch; Elizabeth A Gauthier; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

4.  Plasticity-Related Gene Expression During Eszopiclone-Induced Sleep.

Authors:  Dmitry Gerashchenko; Ravi K Pasumarthi; Thomas S Kilduff
Journal:  Sleep       Date:  2017-07-01       Impact factor: 5.849

5.  The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.

Authors:  Julie Seibt; Sara J Aton; Sushil K Jha; Tammi Coleman; Michelle C Dumoulin; Marcos G Frank
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

6.  The sedating antidepressant trazodone impairs sleep-dependent cortical plasticity.

Authors:  Sara J Aton; Julie Seibt; Michelle C Dumoulin; Tammi Coleman; Mia Shiraishi; Marcos G Frank
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

7.  Effects of three hypnotics on the sleep-wakefulness cycle in sleep-disturbed rats.

Authors:  Kazuaki Shinomiya; Yuki Shigemoto; Junji Omichi; Yoshiaki Utsu; Mitsunobu Mio; Chiaki Kamei
Journal:  Psychopharmacology (Berl)       Date:  2004-01-14       Impact factor: 4.530

8.  Potentiating effect of eszopiclone on GABA(A) receptor-mediated responses in pedunculopontine neurons.

Authors:  Meijun Ye; Edgar Garcia-Rill
Journal:  Sleep       Date:  2009-07       Impact factor: 5.849

9.  Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity.

Authors:  C Kopp; U Rudolph; K Löw; I Tobler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

Review 10.  Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.